Year: 2020
Type: article
Abstract: Pulmonary aspergillosis has been increasingly reported following severe respiratory viral infections. Millions have been infected by SARS-CoV-2, placing large numbers of patients at-risk for COVID-19 associated pulmonary aspergillosis (CAPA). Prompt recognition of this syndrome and is paramount to improve outcomes.
Source: Open Forum Infectious Diseases
DOI: 10.1093/ofid/ofaa242
Institutions: University of California Davis Medical Center, University of California, Davis, University of Cologne, German Center for Infection Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne, University of Alabama at Birmingham, UAB Medicine, The University of Texas at San Antonio Health Science Center, South Texas Veterans Health Care System, Medical University of Graz, University of California San Diego, University of Pittsburgh, VA Pittsburgh Healthcare System
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,053
OpenAlex ID: W3036050467
